SoftServe Acknowledged as a Major Contender in Healthcare Analytics Services by Everest Group
7.12.2021 15:05:00 EET | Business Wire | Press release
SoftServe, a leading digital authority and consulting company, has been recognized by Everest Group as a Major Contender in healthcare analytics services, according to Everest Group’s Healthcare Analytics Services PEAK Matrix® Assessment 2022. The recognition marks the first year that SoftServe has participated in Everest Group’s annual assessment of the healthcare analytics services marketplace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005472/en/
SoftServe Positioned as a Major Contender in Healthcare Analytics Services by Everest Group (Graphic: Business Wire)
“Our positioning as a Major Contender in Healthcare Analytics is a validation of our strong healthcare domain and technology expertise and of our ability to accelerate business outcomes across the healthcare landscape,” said Adam Gabrault, Executive Vice President of Healthcare and Life Sciences at SoftServe. “We are thankful to our customers for their partnership and will continue on our unwavering commitment to delivering value to our healthcare clients as a trusted adviser and technology partner that enables them to keep their data-driven decision making in sync with evolving demands of the healthcare ecosystem.”
The Healthcare Analytics Services PEAK Matrix Assessment 2022 focuses on the market trends for healthcare analytics services and provides a comparative assessment of 25 service and technology providers based on such factors as vision, capabilities/functionality, talent availability, market success/impact, and cost. The assessment is based on Everest Group's annual RFI process for the calendar year 2021 and includes interactions with leading service providers, client reference checks, and ongoing analysis of the healthcare analytics services market.
SoftServe was positioned as a Major Contender due to its strong execution capabilities across the analytics value chain and a good mix of platforms spanning the entire analytics space from data management to advanced analytics. Everest Group also mentions SoftServe’s investments in strengthening professional expertise through SoftServe University, professional certifications, and a dedicated Center of Excellence. The report also highlights clients’ acknowledgment of SoftServe’s delivery excellence and the quality of its talent as its major strengths.
“Analytics has emerged as a secular theme for healthcare enterprises, as they make their shift towards value-based care, a better stakeholder experience, and improved quality of care. Enterprises are now using it for improved financial and care outcomes, as well as for operational efficiency," said Chunky Satija, Practice Director at Everest Group. "SoftServe, with its investments in building platforms and accelerators such as Human360º platform and Patient Leakage Analytics is well-positioned to assist enterprises in their analytics journey. Its IP-led portfolio of offerings, accompanied by strong execution capabilities and quality of talent has enabled it to be positioned as a Major Contender in Everest Group’s Healthcare Analytics Services PEAK Matrix® Assessment 2022.”
View an extract of the Healthcare Analytics Services PEAK Matrix Assessment 2022 here. To learn more about SoftServe’s healthcare offerings, please visit its Healthcare & Life Sciences page.
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.
SoftServe delivers open innovation—from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience are built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.
Visit our website, blog, LinkedIn, Facebook, and Twitter pages.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005472/en/
Contact information
SoftServe Media Contacts
Paul Jones
Senior Manager, Analyst and Public Relations
pjone@softserveinc.com
Andrew Kavka
Lead Analyst and Public Relations Specialist
akavk@softserveinc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa30.4.2026 16:30:00 EEST | Press release
Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions. Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements. “Collaborati
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 16:22:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 16:00:00 EEST | Press release
Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity. “Agen
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 16:00:00 EEST | Press release
Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant information, suggests next actions, and maintains conversational flow to keep every interaction effortless and engaging. Delivered in short, s
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 15:05:00 EEST | Press release
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People living with lupus continue to face significant challenges in achieving disease control and are very often affected by itchy, painful and stigmatized skin manifestations,” said David Weinreich, Global Head of R&D, Merck. “With enpatoran, we aim to target the underlying drivers of lupus and redefine how to approach the disease by understanding both visible skin manifestations and systemic activity.” Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor designed to modulate pathways central to lupus-related inflammatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom